NCT05039801 2025-10-14IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsM.D. Anderson Cancer CenterPhase 1 Recruiting54 enrolled
NCT03144778 2021-03-18Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell CancerM.D. Anderson Cancer CenterPhase 1 Completed39 enrolled